Endocrinology, Vol 123, 1611-1618, Copyright © 1988 by Endocrine Society

ARTICLES

Identification and characterization of metalloproteinase inhibitor activity in human ovarian follicular fluid

TE Curry Jr, SL Sanders, NG Pedigo, RS Estes, EA Wilson and MW Vernon
Department of Obstetrics and Gynecology, University of Kentucky, Lexington 40536.

Metalloproteinase inhibitors regulate collagenase activity in the extracellular matrix. To assess the role of metalloproteinase inhibitors in the ovulatory process, inhibitor activity was examined in human follicular fluid collected 2-4 h before ovulation. The relationship between inhibitor activity and steroid content was determined, and the inhibitors were partially purified and characterized. Inhibitory activity in follicular fluid (n = 25) correlated with both follicular estradiol (P less than 0.001) and progesterone (P less than 0.02) concentrations per follicle. Chromatographic separation of the follicular fluid on Sepharose 6B isolated two peaks of inhibitory activity. The inhibitor from the small mol wt (Mr) peak shared many of the properties of tissue inhibitors of metalloproteinase. It was stable in response to heat (60 C) and methylamine (200 mM), and was destroyed by reduction and alkylation, a procedure reported to destroy previously characterized inhibitors. Partial purification by affinity and ion exchange chromatography demonstrated the inhibitor to be a glycoprotein with an approximate Mr of 28-29K. The large Mr inhibitor had an approximate size of 700K and exhibited many of the characteristics of alpha 2-macroglobulin, a serum- derived metalloproteinase inhibitor. It was sensitive to heat, methylamine, and reduction and alkylation. Thus, follicular fluid contains metalloproteinase inhibitor activity that is steroid related and may be hormonally regulated. Ovarian metalloproteinase inhibitors may act to regulate connective tissue remodeling during follicular rupture.

This article has been cited by other articles:

				T. E. Curry Jr. and K. G. Osteen The Matrix Metalloproteinase System: Changes, Regulation, and Impact throughout the Ovarian and Uterine Reproductive Cycle Endocr. Rev., August 1, 2003; 24(4): 428 - 465. [Abstract] [Full Text] [PDF]

				T. A. Towle, P. C.W. Tsang, R. A. Milvae, M. K. Newbury, and J. A. McCracken Dynamic In Vivo Changes in Tissue Inhibitors of Metalloproteinases 1 and 2, and Matrix Metalloproteinases 2 and 9, During Prostaglandin F2{alpha}-Induced Luteolysis in Sheep Biol Reprod, May 1, 2002; 66(5): 1515 - 1521. [Abstract] [Full Text]

				A. Makrigiannakis, G. Coukos, M. Christofidou-Solomidou, B. J. Gour, G. L. Radice, O. Blaschuk, and C. Coutifaris N-Cadherin-Mediated Human Granulosa Cell Adhesion Prevents Apoptosis : A Role in Follicular Atresia and Luteolysis? Am. J. Pathol., May 1, 1999; 154(5): 1391 - 1406. [Abstract] [Full Text] [PDF]

				S. Goldman, M. Dirnfeld, H. Abramovici, and Z. Kraiem Triiodothyronine and Follicle-Stimulating Hormone, Alone and Additively Together, Stimulate Production of the Tissue Inhibitor of Metalloproteinases-1 in Cultured Human Luteinized Granulosa Cells J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1869 - 1873. [Abstract] [Full Text] [PDF]